Balyasny Asset Management’s CVS Health CVS Stock Holding History

Balyasny Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.86M	Sell	53,800 -27,800	-34%	-$2.14M	0.01%	1475
2025 Q4	$6.48M	Sell	81,600 -260,700	-76%	-$20.6M	0.01%	1261
2025 Q3	$25.8M	Buy	342,300 +248,000	+263%	+$17M	0.03%	604
2025 Q2	$6.5M	Buy	94,300 +59,900	+174%	+$3.93M	0.01%	1168
2025 Q1	$2.33M	Sell	34,400 -23,600	-41%	-$1.41M	﹤0.01%	1634
2024 Q4	$2.6M	Buy	58,000 +8,900	+18%	+$499K	﹤0.01%	1574
2024 Q3	$3.09M	Hold	49,100	–	–	0.01%	1484
2024 Q2	$2.9M	Buy	+49,100	New	+$3.07M	0.01%	1398
2024 Q1	–	Sell	-100,000	Closed	-$7.9M	–	2713
2023 Q4	$7.9M	Buy	+100,000	New	+$7.12M	0.01%	945
2023 Q1	–	Sell	-10,000	Closed	-$932K	–	2741
2022 Q4	$932K	Buy	+10,000	New	+$965K	﹤0.01%	1688
2021 Q3	–	Sell	-8,900	Closed	-$743K	–	2018
2021 Q2	$743K	Buy	+8,900	New	+$729K	﹤0.01%	1426

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Balyasny Asset Management's CVS Position: Q1 2026 in Review

Balyasny Asset Management increased its CVS Health (CVS) stake by 27% in Q1 2026, buying an estimated $19.5M and bringing the position to 1,191,023 shares worth $85.5M. The position accounts for 0.11% of the portfolio, ranked #193.

Balyasny Asset Management first reported a position in CVS in Q4 2013 and has held it in 39 quarters since. The position peaked at $98.1M in Q2 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Balyasny Asset Management held 1,191,023 shares of CVS Health worth $85.5M as of Q1 2026.
Balyasny Asset Management bought 252,966 CVS Health shares in Q1 2026, an estimated $19.5M.
CVS Health made up 0.11% of Balyasny Asset Management's portfolio in Q1 2026, its #193 holding.
Balyasny Asset Management first reported a position in CVS Health in Q4 2013 and has held it in 39 quarters since.
Balyasny Asset Management's CVS Health position peaked at $98.1M in Q2 2025.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.